BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35870090)

  • 21. Outcomes in Severe Hyponatremia Treated With and Without Desmopressin.
    MacMillan TE; Cavalcanti RB
    Am J Med; 2018 Mar; 131(3):317.e1-317.e10. PubMed ID: 29061503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Osmotic demyelination syndrome and overly rapid correction of hyponatremia].
    Grosjean A; Thieffry C; Marti C
    Rev Med Suisse; 2022 Oct; 18(801):2012-2018. PubMed ID: 36314091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overcorrection and undercorrection with fixed dosing of bolus hypertonic saline for symptomatic hyponatremia.
    Pelouto A; Refardt JC; Christ-Crain M; Zandbergen AAM; Hoorn EJ
    Eur J Endocrinol; 2023 Mar; 188(3):322-330. PubMed ID: 36881992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of severe symptomatic hyponatremia.
    Tandukar S; Rondon-Berrios H
    Physiol Rep; 2019 Nov; 7(21):e14265. PubMed ID: 31691515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of intranasal desmopressin therapy with overcorrection of severe hyponatremia: A retrospective, propensity score-based, single-center cohort study.
    Jingushi N; Tsuzuki S; Fujii K; Uenishi N; Iwata M; Terasawa T
    J Crit Care; 2021 Aug; 64():53-61. PubMed ID: 33794467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of hyponatremia in children with gastroenteritis treated with hypotonic intravenous fluids.
    Hanna M; Saberi MS
    Pediatr Nephrol; 2010 Aug; 25(8):1471-5. PubMed ID: 20108002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of Overcorrection in Rapid Intermittent Bolus vs Slow Continuous Infusion Therapies of Hypertonic Saline for Patients With Symptomatic Hyponatremia: The SALSA Randomized Clinical Trial.
    Baek SH; Jo YH; Ahn S; Medina-Liabres K; Oh YK; Lee JB; Kim S
    JAMA Intern Med; 2021 Jan; 181(1):81-92. PubMed ID: 33104189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics, symptoms, and outcome of severe dysnatremias present on hospital admission.
    Arampatzis S; Frauchiger B; Fiedler GM; Leichtle AB; Buhl D; Schwarz C; Funk GC; Zimmermann H; Exadaktylos AK; Lindner G
    Am J Med; 2012 Nov; 125(11):1125.e1-1125.e7. PubMed ID: 22939097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Equivalent Efficacy and Decreased Rate of Overcorrection in Patients With Syndrome of Inappropriate Secretion of Antidiuretic Hormone Given Very Low-Dose Tolvaptan.
    Hanna RM; Velez JC; Rastogi A; Nguyen MK; Kamgar MK; Moe K; Arman F; Hasnain H; Nobakht N; Selamet U; Kurtz I
    Kidney Med; 2020; 2(1):20-28. PubMed ID: 32734225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disorders of Sodium.
    Alindogan A; Joseph R
    Emerg Med Clin North Am; 2023 Nov; 41(4):697-709. PubMed ID: 37758418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of two different tolvaptan doses in the treatment of hyponatremia in the Emergency Department.
    Castello LM; Baldrighi M; Panizza A; Bartoli E; Avanzi GC
    Intern Emerg Med; 2017 Oct; 12(7):993-1001. PubMed ID: 27444946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ten pitfalls in the proper management of patients with hyponatremia.
    Filippatos TD; Liamis G; Elisaf MS
    Postgrad Med; 2016 Jun; 128(5):516-22. PubMed ID: 27153450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of severe hyponatremia (<120mEq/l)].
    Decaux G
    Rev Med Brux; 2001 Oct; 22(5):413-9. PubMed ID: 11723783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uremia Preventing Osmotic Demyelination Syndrome Despite Rapid Hyponatremia Correction.
    Annangi S; Nutalapati S; Naramala S; Yarra P; Bashir K
    J Investig Med High Impact Case Rep; 2020; 8():2324709620918095. PubMed ID: 32410468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A practical treatment of hyponatraemia].
    Overgaard-Steensen C; Ring T
    Ugeskr Laeger; 2012 Apr; 174(15):1016-9. PubMed ID: 22487408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and Management of Hyponatremia: A Review.
    Adrogué HJ; Tucker BM; Madias NE
    JAMA; 2022 Jul; 328(3):280-291. PubMed ID: 35852524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyponatremia management among patients admitted to tertiary hospital: A retrospective evaluation.
    Zurnuq S; Aljurfi M; Albekery M; Shawaqfeh MS; Elmubark A; Vasudevan S; Alharbi S; Alkatheri M; Albekairy AM; Al Katheri AA
    SAGE Open Med; 2022; 10():20503121221095333. PubMed ID: 35509952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of hyponatremia.
    Sterns RH; Hix JK; Silver S
    Curr Opin Nephrol Hypertens; 2010 Sep; 19(5):493-8. PubMed ID: 20539224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Severe Hyponatremia.
    Sterns RH
    Clin J Am Soc Nephrol; 2018 Apr; 13(4):641-649. PubMed ID: 29295830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A standard hemodialysis prescription to prevent osmotic demyelination in hyponatremic patients requiring dialysis.
    Koc NS; Yildirim T; Girgin S; Onal C; Tahillioglu Y; Yilmaz R; Arici M; Altun B; Erdem Y
    Ther Apher Dial; 2022 Dec; 26(6):1182-1186. PubMed ID: 35199958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.